GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rhinomed Ltd (ASX:RNO) » Definitions » Pretax Margin %

Rhinomed (ASX:RNO) Pretax Margin % : -152.95% (As of Jun. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Rhinomed Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Rhinomed's Pre-Tax Income for the six months ended in Jun. 2023 was A$-6.25 Mil. Rhinomed's Revenue for the six months ended in Jun. 2023 was A$4.09 Mil. Therefore, Rhinomed's pretax margin for the quarter that ended in Jun. 2023 was -152.95%.

The historical rank and industry rank for Rhinomed's Pretax Margin % or its related term are showing as below:

ASX:RNO' s Pretax Margin % Range Over the Past 10 Years
Min: -1859.24   Med: -212.78   Max: -57.99
Current: -145.97


ASX:RNO's Pretax Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -0.745 vs ASX:RNO: -145.97

Rhinomed Pretax Margin % Historical Data

The historical data trend for Rhinomed's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhinomed Pretax Margin % Chart

Rhinomed Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -180.43 -203.79 -221.77 -57.99 -145.97

Rhinomed Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -161.72 -86.66 -37.92 -137.53 -152.95

Competitive Comparison of Rhinomed's Pretax Margin %

For the Medical Devices subindustry, Rhinomed's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhinomed's Pretax Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rhinomed's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Rhinomed's Pretax Margin % falls into.



Rhinomed Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Rhinomed's Pretax Margin for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=-10.907/7.472
=-145.97 %

Rhinomed's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=-6.254/4.089
=-152.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rhinomed  (ASX:RNO) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Rhinomed Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Rhinomed's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Rhinomed (ASX:RNO) Business Description

Traded in Other Exchanges
Address
132 Gwynne Street, Level 1, Cremorne, VIC, AUS, 3121
Rhinomed Ltd is a medical technology company, with a patented nasal technology platform. It is engaged in the research, development and commercialization of consumer and medical devices including nasal, respiratory and nasal drug delivery technologies. It operates in one segment which is the identification, acquisition, and commercialization of late-stage consumer therapeutic and medical delivery technologies. The products of the company involve Rhinoswab, Mute, Turbine and Rhinoswab Junior. It operates geographically within North, Central, and South America, Asia-Pacific, Europe, Middle East, and Africa. The company earns majority of its revenue from Asia-Pacific.

Rhinomed (ASX:RNO) Headlines

No Headlines